These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23306213)

  • 21. Impact of psychiatric evaluation on patients in geriatric evaluation and management units.
    Matthew WH; Walter C; Cancellaro LA; Hamdy RC
    J Tenn Med Assoc; 1994 Aug; 87(8):329-31. PubMed ID: 7934030
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 23. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 24. [Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales].
    Voigt-Radloff S; Hüll M
    Psychiatr Prax; 2011 Jul; 38(5):221-31. PubMed ID: 21425035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innovative psychosocial approaches in old age psychiatry.
    Yassuda MS; Nunes PV
    Curr Opin Psychiatry; 2009 Nov; 22(6):527-31. PubMed ID: 19633557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Older people, mental health and learning.
    Benbow SM
    Int Psychogeriatr; 2009 Oct; 21(5):799-804. PubMed ID: 19368759
    [No Abstract]   [Full Text] [Related]  

  • 27. Dementia treatment: a German perspective on psychosocial aspects and therapeutic approaches.
    Möller HJ
    Int Psychogeriatr; 1995; 7(3):459-70. PubMed ID: 8821353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychobehavioral disorders in severe dementia].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S5-13. PubMed ID: 15899600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia care. Part 2: understanding and managing behavioural challenges.
    Ouldred E; Bryant C
    Br J Nurs; 2008 Feb 28-Mar 12; 17(4):242-7. PubMed ID: 18414268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of ICT-based neurocognitive and psychosocial rehabilitation programmes in people with mild dementia and mild cognitive impairment using GRADIOR and ehcoBUTLER: study protocol for a randomised controlled trial.
    Vanova M; Irazoki E; García-Casal JA; Martínez-Abad F; Botella C; Shiells KR; Franco-Martín MA
    Trials; 2018 Feb; 19(1):100. PubMed ID: 29433545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 32. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.
    Levy JA; Chelune GJ
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):227-38. PubMed ID: 18004009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary benefits of cognitive rehabilitation for a chronic ethylic patient: effects on disorder consciousness, motivation, and global therapeutic cooperation].
    Siccardi L; Vautel-Pons D; dos Santos MT; Camus N; Louchart de la Chapelle S
    Encephale; 2014 Jun; 40(3):263-70. PubMed ID: 23928068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Memory clinics in community mental health care].
    Marpert M; Roser M
    Psychiatr Prax; 2011 May; 38(4):163-5. PubMed ID: 21547874
    [No Abstract]   [Full Text] [Related]  

  • 35. Minor cognitive deficits and the detection of mild dementia.
    Berg L
    Psychiatr J Univ Ott; 1990 Nov; 15(4):230-1. PubMed ID: 2284377
    [No Abstract]   [Full Text] [Related]  

  • 36. Frontal Behavioural Inventory in the differential diagnosis of dementia.
    Milan G; Lamenza F; Iavarone A; Galeone F; Lorè E; de Falco C; Sorrentino P; Postiglione A
    Acta Neurol Scand; 2008 Apr; 117(4):260-5. PubMed ID: 17922889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emotional lability, intrusiveness, and catastrophic reactions.
    Haupt M
    Int Psychogeriatr; 1996; 8 Suppl 3():409-14. PubMed ID: 9154598
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer's Disease: Current Evidences and Future Directions.
    Dourado MC; Laks J
    Curr Alzheimer Res; 2016; 13(10):1100-11. PubMed ID: 27468911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial.
    Li M; Lyu JH; Zhang Y; Gao ML; Li WJ; Ma X
    Medicine (Baltimore); 2017 Dec; 96(51):e9381. PubMed ID: 29390538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia Behavior Disturbance Scale.
    Gauthier S; Baumgarten M; Becker R
    Int Psychogeriatr; 1996; 8 Suppl 3():325-7. PubMed ID: 9154583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.